Selected research
Industry Research
Chemical Drug and Biologic Drug Industry Research Report 2026
Market perspective
The global Chemical Drug and Biologic Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chemical Drug and Biologic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chemical Drug and Biologic Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chemical Drug and Biologic Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chemical Drug and Biologic Drug include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Merck & Co., Roche and Eli Lilly & Co., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chemical Drug and Biologic Drug market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chemical Drug and Biologic Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chemical Drug and Biologic Drug Market by Company
Takeda
Teva
Sanofi
Johnson & Johnson
Novartis
Novo Nordisk
Merck & Co.
Roche
Eli Lilly & Co.
Pfizer
GlaxoSmithKline
Biogen
Bayer
Bristol Myers Squibb
Amgen
AbbVie
AstraZeneca
Gilead Sciences
Boehringer Ingelheim
Astellas
Chemical Drug and Biologic Drug Segment by Type
Chemical Drug
Biologic Drug
Chemical Drug and Biologic Drug Segment by Application
Hospital
Retail Pharmacy
Other
Chemical Drug and Biologic Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical Drug and Biologic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chemical Drug and Biologic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical Drug and Biologic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chemical Drug and Biologic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Drug
- Biologic Drug
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Takeda
- Teva
- Sanofi
- Johnson & Johnson
- Novartis
- Novo Nordisk
- Merck & Co.
- Roche
- Eli Lilly & Co.
- Pfizer
- GlaxoSmithKline
- Biogen
- Bayer
- Bristol Myers Squibb
- Amgen
- AbbVie
- AstraZeneca
- Gilead Sciences
- Boehringer Ingelheim
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chemical Drug and Biologic Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chemical Drug
- 2.2.3 Biologic Drug
- 2.3 Chemical Drug and Biologic Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Chemical Drug and Biologic Drug Breakdown Data by Type
- 3.1 Global Chemical Drug and Biologic Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Type (2027-2032)
4 Chemical Drug and Biologic Drug Breakdown Data by Application
- 4.1 Global Chemical Drug and Biologic Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chemical Drug and Biologic Drug Market Perspective (2021-2032)
- 5.2 Global Chemical Drug and Biologic Drug Growth Trends by Region
- 5.2.1 Global Chemical Drug and Biologic Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chemical Drug and Biologic Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Chemical Drug and Biologic Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Chemical Drug and Biologic Drug Market Dynamics
- 5.3.1 Chemical Drug and Biologic Drug Industry Trends
- 5.3.2 Chemical Drug and Biologic Drug Market Drivers
- 5.3.3 Chemical Drug and Biologic Drug Market Challenges
- 5.3.4 Chemical Drug and Biologic Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chemical Drug and Biologic Drug Players by Revenue
- 6.1.1 Global Top Chemical Drug and Biologic Drug Players by Revenue (2021-2026)
- 6.1.2 Global Chemical Drug and Biologic Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Chemical Drug and Biologic Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chemical Drug and Biologic Drug Head Office and Area Served
- 6.4 Global Chemical Drug and Biologic Drug Players, Product Type & Application
- 6.5 Global Chemical Drug and Biologic Drug Manufacturers Established Date
- 6.6 Global Chemical Drug and Biologic Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chemical Drug and Biologic Drug Market Size (2021-2032)
- 7.2 North America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 7.4 North America Chemical Drug and Biologic Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chemical Drug and Biologic Drug Market Size (2021-2032)
- 8.2 Europe Chemical Drug and Biologic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 8.4 Europe Chemical Drug and Biologic Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chemical Drug and Biologic Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Chemical Drug and Biologic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chemical Drug and Biologic Drug Market Size (2021-2032)
- 10.2 South America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 10.4 South America Chemical Drug and Biologic Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chemical Drug and Biologic Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Chemical Drug and Biologic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Takeda
- 12.1.1 Takeda Company Information
- 12.1.2 Takeda Business Overview
- 12.1.3 Takeda Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.1.4 Takeda Chemical Drug and Biologic Drug Product Portfolio
- 12.1.5 Takeda Recent Developments
- 12.2 Teva
- 12.2.1 Teva Company Information
- 12.2.2 Teva Business Overview
- 12.2.3 Teva Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.2.4 Teva Chemical Drug and Biologic Drug Product Portfolio
- 12.2.5 Teva Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.3.4 Sanofi Chemical Drug and Biologic Drug Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Information
- 12.4.2 Johnson & Johnson Business Overview
- 12.4.3 Johnson & Johnson Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.4.4 Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio
- 12.4.5 Johnson & Johnson Recent Developments
- 12.5 Novartis
- 12.5.1 Novartis Company Information
- 12.5.2 Novartis Business Overview
- 12.5.3 Novartis Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.5.4 Novartis Chemical Drug and Biologic Drug Product Portfolio
- 12.5.5 Novartis Recent Developments
- 12.6 Novo Nordisk
- 12.6.1 Novo Nordisk Company Information
- 12.6.2 Novo Nordisk Business Overview
- 12.6.3 Novo Nordisk Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.6.4 Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio
- 12.6.5 Novo Nordisk Recent Developments
- 12.7 Merck & Co.
- 12.7.1 Merck & Co. Company Information
- 12.7.2 Merck & Co. Business Overview
- 12.7.3 Merck & Co. Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.7.4 Merck & Co. Chemical Drug and Biologic Drug Product Portfolio
- 12.7.5 Merck & Co. Recent Developments
- 12.8 Roche
- 12.8.1 Roche Company Information
- 12.8.2 Roche Business Overview
- 12.8.3 Roche Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.8.4 Roche Chemical Drug and Biologic Drug Product Portfolio
- 12.8.5 Roche Recent Developments
- 12.9 Eli Lilly & Co.
- 12.9.1 Eli Lilly & Co. Company Information
- 12.9.2 Eli Lilly & Co. Business Overview
- 12.9.3 Eli Lilly & Co. Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.9.4 Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio
- 12.9.5 Eli Lilly & Co. Recent Developments
- 12.10 Pfizer
- 12.10.1 Pfizer Company Information
- 12.10.2 Pfizer Business Overview
- 12.10.3 Pfizer Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.10.4 Pfizer Chemical Drug and Biologic Drug Product Portfolio
- 12.10.5 Pfizer Recent Developments
- 12.11 GlaxoSmithKline
- 12.11.1 GlaxoSmithKline Company Information
- 12.11.2 GlaxoSmithKline Business Overview
- 12.11.3 GlaxoSmithKline Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.11.4 GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio
- 12.11.5 GlaxoSmithKline Recent Developments
- 12.12 Biogen
- 12.12.1 Biogen Company Information
- 12.12.2 Biogen Business Overview
- 12.12.3 Biogen Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.12.4 Biogen Chemical Drug and Biologic Drug Product Portfolio
- 12.12.5 Biogen Recent Developments
- 12.13 Bayer
- 12.13.1 Bayer Company Information
- 12.13.2 Bayer Business Overview
- 12.13.3 Bayer Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.13.4 Bayer Chemical Drug and Biologic Drug Product Portfolio
- 12.13.5 Bayer Recent Developments
- 12.14 Bristol Myers Squibb
- 12.14.1 Bristol Myers Squibb Company Information
- 12.14.2 Bristol Myers Squibb Business Overview
- 12.14.3 Bristol Myers Squibb Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.14.4 Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio
- 12.14.5 Bristol Myers Squibb Recent Developments
- 12.15 Amgen
- 12.15.1 Amgen Company Information
- 12.15.2 Amgen Business Overview
- 12.15.3 Amgen Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.15.4 Amgen Chemical Drug and Biologic Drug Product Portfolio
- 12.15.5 Amgen Recent Developments
- 12.16 AbbVie
- 12.16.1 AbbVie Company Information
- 12.16.2 AbbVie Business Overview
- 12.16.3 AbbVie Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.16.4 AbbVie Chemical Drug and Biologic Drug Product Portfolio
- 12.16.5 AbbVie Recent Developments
- 12.17 AstraZeneca
- 12.17.1 AstraZeneca Company Information
- 12.17.2 AstraZeneca Business Overview
- 12.17.3 AstraZeneca Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.17.4 AstraZeneca Chemical Drug and Biologic Drug Product Portfolio
- 12.17.5 AstraZeneca Recent Developments
- 12.18 Gilead Sciences
- 12.18.1 Gilead Sciences Company Information
- 12.18.2 Gilead Sciences Business Overview
- 12.18.3 Gilead Sciences Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.18.4 Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio
- 12.18.5 Gilead Sciences Recent Developments
- 12.19 Boehringer Ingelheim
- 12.19.1 Boehringer Ingelheim Company Information
- 12.19.2 Boehringer Ingelheim Business Overview
- 12.19.3 Boehringer Ingelheim Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.19.4 Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio
- 12.19.5 Boehringer Ingelheim Recent Developments
- 12.20 Astellas
- 12.20.1 Astellas Company Information
- 12.20.2 Astellas Business Overview
- 12.20.3 Astellas Revenue in Chemical Drug and Biologic Drug Business (2021-2026)
- 12.20.4 Astellas Chemical Drug and Biologic Drug Product Portfolio
- 12.20.5 Astellas Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst